MEXILETINE HYDROCHLORIDE
Generic: MEXILETINE HYDROCHLORIDE
Camber PharmaceuticalsManufacturer
ORALRoute
MEXILETINE HYDROCHLORIDEActive Substance
2022-11-09Original Approval
MEXILETINE HYDROCHLORIDE is FDA application ANDA216463, sponsored by ANNORA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
43 reports
2
FATIGUE
32 reports
3
VENTRICULAR TACHYCARDIA
31 reports
4
DYSPNOEA
27 reports
5
NAUSEA
24 reports
6
POOR QUALITY SLEEP
24 reports
7
IMPAIRED WORK ABILITY
23 reports
8
IMPAIRED QUALITY OF LIFE
22 reports
9
PYREXIA
22 reports
10
CARDIAC FAILURE
19 reports